SBIR/STTR Research Award
Developing and Scaling an interactive text messaging tool to help pregnantsmoker
Award amount
$1,114,167Program and phase
SBIR · Phase IIAward year
2014Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- Voxiva, Inc
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- PA12-088
- Topic code
- NIDA
Research abstract
DESCRIPTION (provided by applicant): There is no more important target audience for smoking cessation efforts than pregnant women. The goal of this Fast Track project is to establish the scientific and technical feasibility of using an interactive text- and web-based application to support smoking cessation among pregnant women. This project aims to develop the first-ever text message based smoking cessation product for pregnant women (quit4babySM), conduct a randomized trial to pilot test quit4baby and develop a plan for disseminating quit4baby.This project is innovative because it offers an intensive, interactive and personalized way to reach a population at high risk - pregnant smokers - with a set of evidence and theory-based tools to support smoking cessation. It also builds upon an existing national text-based educational program for pregnant women and new mothers, text4baby, which to date has enrolled over 260,000 enrollees, and is thus in a position to be scaled rapidly and cost-effectively if the
Technology keywords
Not reported
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Wearable Wireless Respiratory Monitoring System that Detects and Predicts Opioid Induced Respiratory Depression
- Building and testing the Life Enhancement and Advocacy Programming digital training tool (LEAPLink) to better serve people with lived experience of homelessness and substance use disorder
- A digital intervention to decrease self-stigma among pregnant and postpartum women with opioid use disorder
- Development of medication for the treatment of respiratory depression due to opioid (prescribed or illicit) overdose/multidrug (polysubstance) overdose in a hospital or community setting.
- Creation and Validation of the Dose-Opioid-Source Evaluation tool (DOSE) - a Robust Opioid Use Clinical Outcome Assessment for Qualification as an FDA Medical Device Development Tool (MDDT)